Cassava Sciences, Inc.

... ...
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Other
VRXValeant Pharmaceuticals International, Inc. -1.89%27.0014.1%$158.87m
HZNPHorizon Therapeutics Plc -0.95%80.435.6%$158.03m
ACRSAclaris Therapeutics, Inc. -4.57%17.975.3%$136.21m
CTLTCatalent, Inc. -0.13%119.672.1%$103.91m
BHCBausch Health Cos., Inc. -1.89%27.000.0%$102.08m
JAZZJazz Pharmaceuticals Plc 0.17%167.292.4%$86.77m
ACSTAcasti Pharma, Inc. 18.64%0.760.2%$71.66m
ISRIsoRay, Inc. 2.08%2.462.5%$65.10m
UTHRUnited Therapeutics Corp. -0.26%171.1714.1%$64.58m
AMRNAmarin Corp. Plc -1.43%6.201.5%$50.03m
PRGOPerrigo Co. Plc -0.44%43.286.8%$49.66m
GWPHGW Pharmaceuticals Plc 0.02%136.936.1%$48.40m
SAGESAGE Therapeutics, Inc. 1.85%91.217.6%$46.77m
ARGXargenx SE 6.40%305.360.0%$43.44m
ICLRICON plc 2.72%220.964.2%$41.59m

Company Profile

Cassava Sciences, Inc. engages in the development of novel drugs and diagnostics. It focuses on developing product candidates intended for the treatment of Alzheimer’s disease, including PTI-125 and PTI-125Dx. The company was founded by Remi Barbier and Barry M. Sherman in May 1998 and is headquartered in Austin, TX.